Abortion incidence and service availability in the United States, 2020.
Journal
Perspectives on sexual and reproductive health
ISSN: 1931-2393
Titre abrégé: Perspect Sex Reprod Health
Pays: United States
ID NLM: 101140654
Informations de publication
Date de publication:
12 2022
12 2022
Historique:
pubmed:
21
11
2022
medline:
23
12
2022
entrez:
20
11
2022
Statut:
ppublish
Résumé
This study provides a baseline assessment of abortion incidence and service delivery prior to Roe v. Wade being overturned. We collected information from all facilities known to have provided abortion services in the United States in 2019 and 2020. We examined abortion incidence by state, region and nationally and combined data on number of abortions with population data to estimate abortion rates. We also examined the number of abortion clinics, trends in medication abortion and service disruptions and changes in abortion protocols that occurred during the COVID-19 pandemic. We compare these findings to those of our prior Abortion Provider Census, which collected information for 2017. We documented 930,160 abortions in 2020, an 8% increase from 2017. Between 2017 and 2020, abortion incidence increased in all four regions of the country and in a majority of states. The total number of clinics providing abortion care remained stable nationally but increased in the Midwest and the West and declined in the Northeast and South. There were 492,210 medication abortions in 2020, a 45% increase from 2017. A substantial minority of clinics adjusted protocols in response to COVID, most commonly adopting remote pre- and post-abortion counseling. This study did not address factors behind the increase in abortion. However, this report demonstrates that the need for abortion care was growing just prior to the overturning Roe v. Wade, and the impact of this decision will be even more far-reaching than previously expected.
Sections du résumé
BACKGROUND
This study provides a baseline assessment of abortion incidence and service delivery prior to Roe v. Wade being overturned.
METHODS
We collected information from all facilities known to have provided abortion services in the United States in 2019 and 2020. We examined abortion incidence by state, region and nationally and combined data on number of abortions with population data to estimate abortion rates. We also examined the number of abortion clinics, trends in medication abortion and service disruptions and changes in abortion protocols that occurred during the COVID-19 pandemic. We compare these findings to those of our prior Abortion Provider Census, which collected information for 2017.
RESULTS
We documented 930,160 abortions in 2020, an 8% increase from 2017. Between 2017 and 2020, abortion incidence increased in all four regions of the country and in a majority of states. The total number of clinics providing abortion care remained stable nationally but increased in the Midwest and the West and declined in the Northeast and South. There were 492,210 medication abortions in 2020, a 45% increase from 2017. A substantial minority of clinics adjusted protocols in response to COVID, most commonly adopting remote pre- and post-abortion counseling.
DISCUSSION
This study did not address factors behind the increase in abortion. However, this report demonstrates that the need for abortion care was growing just prior to the overturning Roe v. Wade, and the impact of this decision will be even more far-reaching than previously expected.
Identifiants
pubmed: 36404279
doi: 10.1363/psrh.12215
pmc: PMC10099841
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
128-141Informations de copyright
© 2022 Guttmacher Institute. Perspectives on Sexual and Reproductive Health published by Wiley Periodicals LLC on behalf of University of Ottawa.
Références
Natl Vital Stat Rep. 2021 Feb;70(17):1-50
pubmed: 35157571
J Adolesc Health. 2018 Aug;63(2):253-256
pubmed: 30149926
Perspect Sex Reprod Health. 2022 Sep;54(3):68-79
pubmed: 35790127
Perspect Sex Reprod Health. 2022 Dec;54(4):128-141
pubmed: 36404279
Lancet Reg Health Am. 2022 Mar 04;10:100214
pubmed: 36777689
N Engl J Med. 2020 Aug 6;383(6):508-510
pubmed: 32757520
Perspect Sex Reprod Health. 2020 Dec;52(4):217-225
pubmed: 33289197
Perspect Sex Reprod Health. 2017 Mar;49(1):7-16
pubmed: 28245088
Contraception. 2018 Jan;97(1):14-21
pubmed: 29038071
BMJ Sex Reprod Health. 2022 Jan;48(e1):e38-e43
pubmed: 33789954
JAMA. 2017 Jan 24;317(4):437-439
pubmed: 28114666
Sex Res Social Policy. 2022;19(2):541-548
pubmed: 33777258
Contracept X. 2021 Feb 08;3:100060
pubmed: 33665606
Perspect Sex Reprod Health. 2006 Jun;38(2):106-11
pubmed: 16772192
Contraception. 2021 Jul;104(1):77-81
pubmed: 33894247
NCHS Data Brief. 2020 Oct;(388):1-8
pubmed: 33151146
Perspect Sex Reprod Health. 2008 Mar;40(1):6-16
pubmed: 18318867
Obstet Gynecol. 2020 Jun;135(6):1296-1305
pubmed: 32459421
Contraception. 2020 Jun;101(6):361-366
pubmed: 32305289
JAMA Netw Open. 2021 May 3;4(5):e2111852
pubmed: 34019085
Am J Public Health. 2021 Aug;111(8):1504-1512
pubmed: 34185578
Obstet Gynecol. 2019 Aug;134(2):343-350
pubmed: 31306317
Contraception. 2018 Apr;97(4):287-291
pubmed: 29030227
Contraception. 2019 Nov;100(5):374-379
pubmed: 31202816
Obstet Gynecol. 2015 Nov;126(5):917-927
pubmed: 26444110
JAMA. 2021 Feb 16;325(7):691-693
pubmed: 33393997
Perspect Sex Reprod Health. 2017 Mar;49(1):17-27
pubmed: 28094905
Best Pract Res Clin Obstet Gynaecol. 2020 Feb;63:87-110
pubmed: 31859163